Personalized Medicine in lung Cancer

The era of personalized treatment for lung cancer will involve a comprehensive genomic characterization of adenocarcinoma, squamous-cell carcinoma, and small-cell carcinoma into various subtypes. Precision medicine is to develop treatments that exploit weak spots in tumor cells to destroy only the cancer cells (as compared to traditional chemotherapy and radiation). Weak spots have been found in two genes, EGFR and ALK, both found in adenocarcinoma NSCLC.

  • Lung cancer surgery
  • Management of Chemotherpay
  • Non-smallcell lung cancer
  • Pathogenesis
  • Lung cancer clinical trials and research

Related Conference of Personalized Medicine in lung Cancer

September 25-26, 2025

5th World Pathology Conference

Amsterdam, Netherlands
December 11-12, 2025

6th International Conference on Breast Pathology and Cancer Diagnosis

Amsterdam, Netherlands
March 26-27, 2026

24th Annual Pathology Congress

Dubai, UAE
June 22-23, 2026

24th European Pathology Congress

Paris, France

Personalized Medicine in lung Cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in